BMI and Mortality: The Diabetes-Obesity Paradox Examined in a Large US Cohort.

IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Rebecca Baqiyyah Conway, Jooyoun Song, M Kathleen Figaro, Jyothi Sri Lokanadham, Wei Perng, Tessa Lee Crume, William J Blot
{"title":"BMI and Mortality: The Diabetes-Obesity Paradox Examined in a Large US Cohort.","authors":"Rebecca Baqiyyah Conway, Jooyoun Song, M Kathleen Figaro, Jyothi Sri Lokanadham, Wei Perng, Tessa Lee Crume, William J Blot","doi":"10.2147/DMSO.S491681","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/objectives: </strong>BMI is a major risk factor for diabetes incidence, but a controversial predictor of mortality among those with diabetes.</p><p><strong>Subjects/methods: </strong>We conducted a mortality follow-up (2002-2019) of participants aged 40-79 with young-onset (diagnosed < age 30, n = 1335), older-onset (diagnosed ≥ 30, n = 15,194), and without (n = 62,295) diabetes at cohort entry. Cox analysis with age as the time scale assessing mortality according to BMI after adjusting for multiple potential confounding factors was used.</p><p><strong>Results: </strong>Mean baseline age and diabetes duration at cohort entry were 50.1 and 29.4 years and 55.3 and 7.7 years among those with young- and older-onset diabetes, respectively. During an average of 12.3 years of follow-up, 47% of the young-onset, 40% of the older-onset diabetes, and 22.6% of those without diabetes at cohort entry died. In multivariable adjusted analyses, compared to a BMI of 18.5-<25 kg/m<sup>2</sup>, HRs (95% CIs) were 4.10 (1.65-10.18), 0.69 (0.54-0.88), 0.81 (0.63-1.05), 0.64 (0.48-0.86) and 0.64 (0.54-0.77) for BMI categories <18.5, 25-<30 30-<35, 35-<40, 40+ kg/m<sup>2</sup> in those with young-onset diabetes. Corresponding HRs (95% CIs) were 2.02 (1.54-2.67), 0.74 (0.68-0.80), 0.74 (0.68-0.80), 0.83 (0.75-0.91) and 1.09 (0.99-1.19) in those with older-onset diabetes, and 1.50 (1.36-1.67), 0.76 (0.73-0.79), 0.73 (0.70-0.77), 0.83 (0.78-0.89) and 1.03 (0.95-1.10) in those without diabetes. Results were generally similar in analyses stratified by smoking status, gender, race and among those on insulin therapy.</p><p><strong>Conclusion: </strong>Among this low socioeconomic status population with diabetes, overweight and obesity tend to be inversely associated with mortality. Risk factors for complications of diabetes other than BMI may be more clinically relevant when treating patients with diabetes.</p>","PeriodicalId":11116,"journal":{"name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","volume":"18 ","pages":"1195-1206"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12013635/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DMSO.S491681","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background/objectives: BMI is a major risk factor for diabetes incidence, but a controversial predictor of mortality among those with diabetes.

Subjects/methods: We conducted a mortality follow-up (2002-2019) of participants aged 40-79 with young-onset (diagnosed < age 30, n = 1335), older-onset (diagnosed ≥ 30, n = 15,194), and without (n = 62,295) diabetes at cohort entry. Cox analysis with age as the time scale assessing mortality according to BMI after adjusting for multiple potential confounding factors was used.

Results: Mean baseline age and diabetes duration at cohort entry were 50.1 and 29.4 years and 55.3 and 7.7 years among those with young- and older-onset diabetes, respectively. During an average of 12.3 years of follow-up, 47% of the young-onset, 40% of the older-onset diabetes, and 22.6% of those without diabetes at cohort entry died. In multivariable adjusted analyses, compared to a BMI of 18.5-<25 kg/m2, HRs (95% CIs) were 4.10 (1.65-10.18), 0.69 (0.54-0.88), 0.81 (0.63-1.05), 0.64 (0.48-0.86) and 0.64 (0.54-0.77) for BMI categories <18.5, 25-<30 30-<35, 35-<40, 40+ kg/m2 in those with young-onset diabetes. Corresponding HRs (95% CIs) were 2.02 (1.54-2.67), 0.74 (0.68-0.80), 0.74 (0.68-0.80), 0.83 (0.75-0.91) and 1.09 (0.99-1.19) in those with older-onset diabetes, and 1.50 (1.36-1.67), 0.76 (0.73-0.79), 0.73 (0.70-0.77), 0.83 (0.78-0.89) and 1.03 (0.95-1.10) in those without diabetes. Results were generally similar in analyses stratified by smoking status, gender, race and among those on insulin therapy.

Conclusion: Among this low socioeconomic status population with diabetes, overweight and obesity tend to be inversely associated with mortality. Risk factors for complications of diabetes other than BMI may be more clinically relevant when treating patients with diabetes.

BMI和死亡率:在美国一个大型队列中检验的糖尿病-肥胖悖论。
背景/目的:BMI是糖尿病发病率的主要危险因素,但在糖尿病患者中,它是一个有争议的死亡率预测指标。受试者/方法:我们对年龄在40-79岁之间的参与者进行了死亡率随访(2002-2019),这些参与者在队列入组时患有年轻发病(诊断年龄< 30岁,n = 1335)、老年发病(诊断年龄≥30岁,n = 15,194)和无糖尿病(n = 62,295)。采用Cox分析,以年龄为时间尺度,在调整多种潜在混杂因素后,根据BMI评估死亡率。结果:队列入组时的平均基线年龄和糖尿病病程分别为50.1岁和29.4岁,年轻和老年糖尿病患者分别为55.3岁和7.7岁。在平均12.3年的随访期间,47%的年轻发病糖尿病患者、40%的老年发病糖尿病患者和22.6%的非糖尿病患者在队列入组时死亡。在多变量调整分析中,与BMI为18.5-2的患者相比,BMI 2类患者的hr (95% ci)分别为4.10(1.65-10.18)、0.69(0.54-0.88)、0.81(0.63-1.05)、0.64(0.48-0.86)和0.64(0.54-0.77)。早发糖尿病组相应的hr (95% ci)分别为2.02(1.54-2.67)、0.74(0.68-0.80)、0.74(0.68-0.80)、0.83(0.75-0.91)、1.09(0.99-1.19),无糖尿病组相应的hr (95% ci)分别为1.50(1.36-1.67)、0.76(0.73-0.79)、0.73(0.70-0.77)、0.83(0.78-0.89)、1.03(0.95-1.10)。在按吸烟状况、性别、种族和接受胰岛素治疗的人群进行分层的分析中,结果大致相似。结论:在低社会经济地位的糖尿病人群中,超重和肥胖与死亡率呈负相关。在治疗糖尿病患者时,BMI以外的糖尿病并发症的危险因素可能更具有临床相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.90
自引率
6.10%
发文量
431
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信